Literature DB >> 30168855

Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington's disease.

Dika Kuljis1,2, Takashi Kudo3,4, Yu Tahara3, Cristina A Ghiani3,5, Christopher S Colwell3.   

Abstract

Disturbances in sleep/wake cycle are a common complaint of individuals with Huntington's disease (HD) and are displayed by HD mouse models. The underlying mechanisms, including the possible role of the circadian timing system, are not well established. The BACHD mouse model of HD exhibits disrupted behavioral and physiological rhythms, including decreased electrical activity in the central circadian clock (suprachiasmatic nucleus, SCN). In this study, electrophysiological techniques were used to explore the ionic underpinning of the reduced spontaneous neural activity in male mice. We found that SCN neural activity rhythms were lost early in the disease progression and was accompanied by loss of the normal daily variation in resting membrane potential in the mutant SCN neurons. The low neural activity could be transiently reversed by direct current injection or application of exogenous N-methyl-d-aspartate (NMDA) thus demonstrating that the neurons have the capacity to discharge at WT levels. Exploring the potassium currents known to regulate the electrical activity of SCN neurons, our most striking finding was that these cells in the mutants exhibited an enhancement in the large-conductance calcium activated K+ (BK) currents. The expression of the pore forming subunit (Kcnma1) of the BK channel was higher in the mutant SCN. We found a similar decrease in daytime electrical activity and enhancement in the magnitude of the BK currents early in disease in another HD mouse model (Q175). These findings suggest that SCN neurons of both HD models exhibit early pathophysiology and that dysregulation of BK current may be responsible.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  BACHD; BK current; Huntington’s disease; Q175; circadian rhythms; suprachiasmatic nucleus

Mesh:

Substances:

Year:  2018        PMID: 30168855      PMCID: PMC7105277          DOI: 10.1002/jnr.24320

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  67 in total

1.  Daily rhythmicity of large-conductance Ca2+ -activated K+ currents in suprachiasmatic nucleus neurons.

Authors:  Gilbert R Pitts; Hidenobu Ohta; Douglas G McMahon
Journal:  Brain Res       Date:  2006-01-17       Impact factor: 3.252

2.  Age-related decline in circadian output.

Authors:  Takahiro J Nakamura; Wataru Nakamura; Shin Yamazaki; Takashi Kudo; Tamara Cutler; Christopher S Colwell; Gene D Block
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

3.  Fast delayed rectifier potassium current: critical for input and output of the circadian system.

Authors:  Takashi Kudo; Dawn H Loh; Dika Kuljis; Cara Constance; Christopher S Colwell
Journal:  J Neurosci       Date:  2011-02-23       Impact factor: 6.167

4.  Dysregulation of inflammatory responses by chronic circadian disruption.

Authors:  Oscar Castanon-Cervantes; Mingwei Wu; J Christopher Ehlen; Ketema Paul; Karen L Gamble; Russell L Johnson; Rachel C Besing; Michael Menaker; Andrew T Gewirtz; Alec J Davidson
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

5.  Regional specificity of brain atrophy in Huntington's disease.

Authors:  G M Halliday; D A McRitchie; V Macdonald; K L Double; R J Trent; E McCusker
Journal:  Exp Neurol       Date:  1998-12       Impact factor: 5.330

6.  Knockout of the BK β2 subunit abolishes inactivation of BK currents in mouse adrenal chromaffin cells and results in slow-wave burst activity.

Authors:  Pedro L Martinez-Espinosa; Chengtao Yang; Vivian Gonzalez-Perez; Xiao-Ming Xia; Christopher J Lingle
Journal:  J Gen Physiol       Date:  2014-10       Impact factor: 4.086

7.  Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington's disease.

Authors:  Patrick N Pallier; Elizabeth S Maywood; Zhiguang Zheng; Johanna E Chesham; Alexei N Inyushkin; Richard Dyball; Michael H Hastings; A Jennifer Morton
Journal:  J Neurosci       Date:  2007-07-18       Impact factor: 6.167

8.  Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.

Authors:  Liliana B Menalled; Andrea E Kudwa; Sam Miller; Jon Fitzpatrick; Judy Watson-Johnson; Nicole Keating; Melinda Ruiz; Richard Mushlin; William Alosio; Kristi McConnell; David Connor; Carol Murphy; Steve Oakeshott; Mei Kwan; Jose Beltran; Afshin Ghavami; Dani Brunner; Larry C Park; Sylvie Ramboz; David Howland
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  The Q175 mouse model of Huntington's disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep.

Authors:  Dawn H Loh; Takashi Kudo; Danny Truong; Yingfei Wu; Christopher S Colwell
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

10.  BK channel inactivation gates daytime excitability in the circadian clock.

Authors:  Joshua P Whitt; Jenna R Montgomery; Andrea L Meredith
Journal:  Nat Commun       Date:  2016-03-04       Impact factor: 14.919

View more
  7 in total

1.  Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.

Authors:  Benjamin Smarr; Tamara Cutler; Dawn H Loh; Takashi Kudo; Dika Kuljis; Lance Kriegsfeld; Cristina A Ghiani; Christopher S Colwell
Journal:  J Neurosci Res       Date:  2019-07-29       Impact factor: 4.164

2.  Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease.

Authors:  Magali Cabanas; Cristiana Pistono; Laura Puygrenier; Divyangana Rakesh; Yannick Jeantet; Maurice Garret; Yoon H Cho
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 3.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

4.  Impaired inhibitory GABAergic synaptic transmission and transcription studied in single neurons by Patch-seq in Huntington's disease.

Authors:  Foteini Paraskevopoulou; Poorya Parvizi; Gökçe Senger; Nurcan Tuncbag; Christian Rosenmund; Ferah Yildirim
Journal:  Proc Natl Acad Sci U S A       Date:  2021-05-11       Impact factor: 11.205

5.  The sleep and circadian problems of Huntington's disease: when, why and their importance.

Authors:  Z Voysey; S V Fazal; A S Lazar; R A Barker
Journal:  J Neurol       Date:  2020-12-23       Impact factor: 4.849

Review 6.  Systemic manifestation and contribution of peripheral tissues to Huntington's disease pathogenesis.

Authors:  Chia-Lung Chuang; Fabio Demontis
Journal:  Ageing Res Rev       Date:  2021-05-09       Impact factor: 11.788

Review 7.  Do Disruptions in the Circadian Timing System Contribute to Autonomic Dysfunction in Huntington's Disease?

Authors:  Saemi Park; Christopher S Colwell
Journal:  Yale J Biol Med       Date:  2019-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.